neferine has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, P; Liu, C; Liu, S; Pan, Y; Wan, P; Wei, Z; Xu, A; Xu, J; Xu, Q; Yan, B; Yang, G | 1 |
| Chen, J; Liu, ZW; Xing, QC; Yang, RP; Zhong, PC | 1 |
2 other study(ies) available for neferine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Neferine, a novel ROCK1-targeting inhibitor, blocks EMT process and induces apoptosis in non-small cell lung cancer.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Humans; Lung Neoplasms; rho-Associated Kinases | 2023 |
Neferine inhibits the development of lung cancer cells by downregulating TGF-β to regulate MST1/ROS-induced pyroptosis.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Humans; Lung Neoplasms; Mice; Pyroptosis; Reactive Oxygen Species; Transforming Growth Factor beta | 2023 |